Schroder Investment Management Group Eye Point Pharmaceuticals, Inc. Transaction History
Schroder Investment Management Group
- $101 Billion
- Q4 2024
A detailed history of Schroder Investment Management Group transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 270,336 shares of EYPT stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
270,336
Previous 123,933
118.13%
Holding current value
$1.65 Million
Previous $990,000
103.43%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EYPT
# of Institutions
156Shares Held
72.4MCall Options Held
187KPut Options Held
225K-
Cormorant Asset Management, LP Boston, MA8.33MShares$50.8 Million4.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.78MShares$41.4 Million2.1% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.75MShares$35.1 Million0.08% of portfolio
-
Franklin Resources Inc San Mateo, CA4.14MShares$25.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.8MShares$23.2 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $208M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...